These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 19052541

  • 1. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
    Casey DE, Daniel DG, Tamminga C, Kane JM, Tran-Johnson T, Wozniak P, Abi-Saab W, Baker J, Redden L, Greco N, Saltarelli M.
    Neuropsychopharmacology; 2009 Apr; 34(5):1330-8. PubMed ID: 19052541
    [Abstract] [Full Text] [Related]

  • 2. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW.
    Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
    [Abstract] [Full Text] [Related]

  • 3. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
    Citrome L, Casey DE, Daniel DG, Wozniak P, Kochan LD, Tracy KA.
    Psychiatr Serv; 2004 Mar; 55(3):290-4. PubMed ID: 15001730
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [Abstract] [Full Text] [Related]

  • 6. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E, Valsecchi P, Parrinello G, QUERISOLA Group.
    Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 8. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Jan; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 9. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
    Chen JJ, Chan HY, Chen CH, Gau SS, Hwu HG.
    Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
    [Abstract] [Full Text] [Related]

  • 10. Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
    Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y, JAST study group.
    Schizophr Res; 2014 Sep; 158(1-3):213-22. PubMed ID: 25086659
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
    McEvoy JP, Lieberman JA, Perkins DO, Hamer RM, Gu H, Lazarus A, Sweitzer D, Olexy C, Weiden P, Strakowski SD.
    Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657
    [Abstract] [Full Text] [Related]

  • 12. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL.
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [Abstract] [Full Text] [Related]

  • 13. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
    Meltzer HY, Cucchiaro J, Silva R, Ogasa M, Phillips D, Xu J, Kalali AH, Schweizer E, Pikalov A, Loebel A.
    Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992
    [Abstract] [Full Text] [Related]

  • 14. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
    Dossenbach MR, Kratky P, Schneidman M, Grundy SL, Metcalfe S, Tollefson GD, Belmaker RH.
    J Clin Psychiatry; 2001 Nov; 62 Suppl 2():28-34. PubMed ID: 11232749
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R, Abordaje Síntomas Negativos Esquizofrenia Group.
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [Abstract] [Full Text] [Related]

  • 17. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SM, Tajdini M, Ghaleiha A, Akhondzadeh S.
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [Abstract] [Full Text] [Related]

  • 18. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
    Konarzewska B, Waszkiewicz N, Galińska B, Szulc A.
    Neuro Endocrinol Lett; 2013 Jan; 34(4):322-8. PubMed ID: 23803867
    [Abstract] [Full Text] [Related]

  • 19. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM, Baker JD, Wozniak P, Tracy K, Sommerville KW.
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
    Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW.
    J Clin Psychiatry; 2002 Dec; 63(12):1148-55. PubMed ID: 12523875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.